Comments for WYE - Stockpickr! Your Source for Stock Ideas

Comments for WYE

Added By	Comments	Type	Date Added
barrons3	Einhorn's top holdings include long positions in URS (URS), Teradata (TDC), Wyeth(WYE), Cardinal Health (CAH), Market Vectors Gold Miners ETF(GDX), Allegheny Energy (AYE), EMC (EMC, and Einstein Noah (BAGL).	Love	September 09, 2009
barrons3	David Einhorn bought stakes in Pfizer (PFE), Wyeth (WYE), Jones Apparel (JNY), Hess (HES) and Discover (DFS). He raised stakes in SPDR Gold Trust (GLD) and EMC (EMC). His largest holdings are GLD, EMC, URS Corp (URS) and MEMC Elec (WFR).	Love	May 20, 2009
barrons3	The third sign comes from pharma. He said the deal between Pfizer (PFE) Wyeth (WYE) could fetch as much as $60 billion, and spark a wave of other consolidations.	Love	January 29, 2009
Trading Nymph	8:30	Love	December 30, 2008
barrons3	9. Wyeth (WYE). Beats the heck out of me. GlaxoSmith Kline (GSK) looks similar, but Wyeth's is better.	Love	November 20, 2008
stockerblog	3.5%	Love	October 20, 2008
sarah z	From a recent Mad Money show: "Holy cow, they have just killed that stock. We are not going to recommend that company until it yields 5%."	Love	October 17, 2008
sarah z	From a recent Mad Money show: "Holy cow, they have just killed that stock. We are not going to recommend that company until it yields 5%."	Love	October 16, 2008
barrons3	Pfizer (PFE) and Schering-Plough (SGP) continue to invest in R&D, but have battered shares, so they outrank Wyeth (WYE). Regeneron Pharmaceutical (REGN) rates higher than more richly valued biotechs like Amgen (AMGN) or Vertex Pharmaceuticals (VRTX). The idea here is inspired by the value-investing tradition: Buy a dollar of research for fifty cents.	Love	September 27, 2008
High Dividends	7.1%	Love	September 27, 2008
audiocat	Great pipeline. Strong consumer brand names--very popular in Asia.	Love	August 12, 2008
stockerblog	8/11/2008	Love	July 26, 2008
barrons2	Elan (ELN) and Wyeth (WYE) are two biotechs worth watching, according to Pete Najarian.	Love	July 01, 2008
barrons2	Wyeth's (WYE) was real good and it's getting sold off.	Love	April 24, 2008
stockerblog	Effexor	Love	April 21, 2008
barrons2	Jenner said that a play on this drug is risky, but he likes the upside. Elan is riskier but holds a greater possible reward, he said, whereas Wyeth has multiple products and carries less risk.	Love	April 09, 2008
barrons2	It's rare, indeed, even in today's stressed market, that the shares of a major drug company that's fast becoming such a formidable presence in biotech can be had for less than break-up value. A company, moreover, with a strong balance sheet, high margins and a stock that sells at only 12 times earnings. A company that has long been rumored a likely takeover target for a pharma giant like Pfizer (PFE) or Novartis (NVS). A company with a promising therapy for Alzheimer's that, essentially, you get free. And a company with a dividend yield of 2.7%, paying more than a five-year Treasury note while you await the final verdict on bapineuzumab, potentially "the biggest drug of all time."	Love	April 05, 2008
barrons2	In her estimation, Wyeth's stock price suggests that investors do not appreciate the value of these assets. At $40, Rubin contends, investors are effectively "getting the pipeline for free." Her analysis suggests that Wyeth's vaccines, biologics (biotechnology drugs) and OTC assets are worth about $35, or about 90% of the stock price. By 2012, Rubin expects biologics and vaccines to account for about 70% of Wyeth's earnings. She raised her investment rating on the stock to Overweight from Equal Weight, and upped her one-year price target to $48 from $46.	Love	February 23, 2008
Markuci	personal knowledge	Love	February 13, 2008
josephviju	World Ummunization program funding, compelling research pipeline, attractive valuations	Love	December 21, 2007
josephviju	World Ummunization program funding, compelling research pipeline, attractive valuations	Love	December 21, 2007
josephviju	World Ummunization program funding, compelling research pipeline, attractive valuations	Love	December 21, 2007
josephviju	World Ummunization program funding, compelling research pipeline, attractive valuations	Love	December 21, 2007
josephviju	World Ummunization program funding, compelling research pipeline, attractive valuations	Love	December 21, 2007
sbehel	DRUGS AND RESEARCH	Love	November 28, 2007
Mike9807	Long-term position	Love	November 27, 2007
bjbullock	undervalued pharma stock	Love	November 18, 2007
ajain1	great pharma at low price and p/e, good for long term	Love	November 17, 2007
dkind67	2nd cheapest pharma, ahead in altzheimers drug, good momentum	Love	November 12, 2007
paul simenauer	Pharmaceuticals	Love	November 02, 2007